Since its discovery, MALAT1 has become the paradigm of functional alterations of lncRNA in cancer and has been proposed as a potential biomarker with a critical role in several tumors, such as non-small cell lung adenocarcinoma (NSCLC) [100], gastric cancer [101], and colorectal cancer [102]. This evidence concerns the gene MALAT1 and cancer.